MEDIROM Healthcare Technologies Inc.
MRM | NASDAQ
$0.75
-$0.03 (-3.90%)
At close: Sep 21, 2026, 4:00 PM ET
$0.76
+$0.01 (+0.68%)
After-hours:
Sep 21, 2026, 6:07 PM ET
Fiscal Quarter Period Ending | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 611.99M | 3.15B | 4.82B | 3.48B | 3.59B | 3.24B | 3.81B | 1.57B | 1.64B | 2.13B | 992.67M | 678.14M |
Cost of Revenue | 2.13M | 2.81B | 3.15B | 2.9B | 2.7B | 2.56B | 2.72B | 1.17B | 1.11B | 884.45M | 821.72M | 634.61M |
Gross Profit | 609.86M | 341.53M | 1.67B | 576.56M | 889.91M | 678.96M | 1.09B | 407.9M | 528.42M | 179.29M | 170.95M | 43.53M |
Operating Income | 70.63M | -814.63M | 618.57M | -636.67M | -81.32M | -310.26M | 251.85M | -76.85M | -229.49M | -513.99M | -528.93M | -431.43M |
Interest Income | 34.32M | 49.57K | 8K | n/a | 1.06M | 16.86M | 1.62M | 2.67M | 2.47M | 3.09M | 3.25M | 2.7M |
Pretax Income | 64.24M | -671.41M | 632.48M | -584.77M | 371.95M | -351.33M | 338.63M | -79.43M | -181.21M | -440.52M | -414.72M | -421.13M |
Net Income | 63.43M | -671.06M | 730.94M | -582.18M | 470.47M | -355.07M | 330.51M | -90.77M | -234.48M | -260.89M | -48.1M | -221.49M |
Selling & General & Admin | 539.23M | 1.16B | 1.03B | 1.21B | 971.23M | 989.22M | 835.99M | 484.75M | 485.01M | 1.33B | 273.59M | 794.95M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | 22.87M | n/a | n/a | n/a | -1.17M | n/a | 37.61M | -916.3M | 53.25M | -534.27M |
Operating Expenses | 539.23M | 1.16B | 1.05B | 1.21B | 971.23M | 989.22M | 834.81M | 484.65M | 522.62M | 409.47M | 326.84M | 260.68M |
Interest Expense | 60.22M | 25.28M | 29.12M | 20.63M | 19.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 77.68M | n/a | 81.02M | n/a | 135.13M | n/a | 65.48M | 65.48M | 46.23M | 46.23M |
Cost & Expenses | 541.35M | 3.97B | 4.21B | 4.11B | 3.67B | 3.55B | 3.56B | 1.65B | 1.64B | 2.61B | 1.15B | 895.29M |
Income Tax Expense | 811.7K | 126.34K | -94.08M | 3.61M | -98.16M | 3.74M | 8.12M | 11.34M | 260.52M | 27.61M | -97.03M | 9.52M |
Shares Outstanding (Basic) | 7.91M | 7.9M | 5.11M | 4.91M | 5.45M | 4.88M | 6.06M | 4.88M | 4.88M | 4.87M | 4.03M | 4.02M |
Shares Outstanding (Diluted) | 7.91M | 7.9M | 5.85M | 4.91M | 5.45M | 4.88M | 6.06M | 4.88M | 4.88M | 4.87M | 4.03M | 4.02M |
EPS (Basic) | 8.02 | -85.10 | 147.69 | -118.56 | 86.32 | -72.72 | 54.54 | -18.59 | -48.02 | -53.55 | -11.94 | -55.06 |
EPS (Diluted) | 8.02 | -85.10 | 118.73 | -118.56 | 43.16 | -72.72 | 54.54 | -18.59 | -48.03 | -53.55 | -11.95 | -55.06 |
EBITDA | 83.37M | -569.82M | 828.07M | -440.57M | 70.43M | -209.41M | 344.31M | -31.65M | 86.71M | -221.28M | -88.05M | -200.6M |
EBIT | 69.46M | -814.63M | 734.13M | -636.67M | -81.32M | -310.26M | 250.68M | -76.85M | 43.41M | -241.09M | -102.64M | -217.15M |
Depreciation & Amortization | 13.91M | 244.81M | 93.94M | 196.1M | 151.75M | 100.85M | 93.64M | 45.21M | 43.31M | 19.82M | 14.59M | 16.55M |
Add to Watchlist
Select watchlists to add or remove MRM